52 studies found for:    Open Studies | "Testicular Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Conditions: Anxiety Disorder;   Depression;   Fatigue;   Leydig Cell Tumor;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Pain;   Peritoneal Carcinomatosis;   Pseudomyxoma Peritonei;   Recurrent Breast Cancer;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Gestational Trophoblastic Tumor;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Recurrent Uterine Sarcoma;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer
Interventions: Other: questionnaire administration;   Procedure: quality-of-life assessment;   Procedure: psychosocial assessment and care;   Behavioral: behavioral intervention;   Other: cognitive intervention;   Other: educational intervention
22 Recruiting Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Conditions: Leydig Cell Tumor;   Ovarian Sarcoma;   Ovarian Stromal Cancer;   Pseudomyxoma Peritonei;   Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Fallopian Tube Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Primary Peritoneal Cavity Cancer;   Recurrent Uterine Sarcoma;   Recurrent Vaginal Cancer;   Recurrent Vulvar Cancer
Interventions: Radiation: stereotactic body radiation therapy;   Drug: carboplatin;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
23 Recruiting DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Conditions: Pleuropulmonary Blastoma;   Cystic Nephroma;   Ovarian Sertoli-Leydig Cell Tumors;   Ocular Medulloepithelioma;   Nasal Chondromesenchymal Hamartoma
Intervention:
24 Unknown  Peptide Vaccination in Treating Patients With Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Biological: TTK, LY6K, and IMP-3 peptides
25 Unknown  A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Biological: peptide
26 Recruiting Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma
Condition: Melanoma
Intervention: Biological: NY-ESO-1
27 Unknown  Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)
Condition: Esophageal Cancer
Intervention: Biological: vaccination
28 Unknown  Combination Chemotherapy in Treating Male Patients With Germ Cell Tumors
Conditions: Extragonadal Germ Cell Tumor;   Teratoma;   Testicular Germ Cell Tumor
Interventions: Biological: bleomycin sulfate;   Drug: carboplatin;   Drug: cisplatin;   Drug: etoposide phosphate;   Drug: vincristine sulfate
29 Recruiting Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Conditions: Childhood Germ Cell Tumor;   Ovarian Cancer;   Teratoma
Interventions: Drug: carboplatin;   Drug: etoposide;   Drug: ifosfamide;   Drug: paclitaxel;   Drug: thiotepa;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: Mesna;   Biological: filgrastim
30 Recruiting Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Condition: Cancer
Interventions: Drug: cyproheptadine hydrochloride;   Other: placebo
31 Recruiting Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
Conditions: Brain and Central Nervous System Tumors;   Extragonadal Germ Cell Tumor;   Ovarian Cancer;   Teratoma;   Testicular Germ Cell Tumor
Interventions: Biological: pegfilgrastim;   Drug: cisplatin;   Drug: ifosfamide;   Drug: paclitaxel
32 Unknown  Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
Conditions: Bladder Cancer;   Cervical Cancer;   Colorectal Cancer;   Endometrial Cancer;   Gastrointestinal Complications;   Long-term Effects Secondary to Cancer Therapy in Adults;   Ovarian Cancer;   Prostate Cancer;   Radiation Toxicity;   Sarcoma;   Testicular Germ Cell Tumor;   Vaginal Cancer
Interventions: Other: questionnaire administration;   Procedure: gastrointestinal complications management/prevention;   Procedure: quality-of-life assessment
33 Recruiting High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
Conditions: Brain and Central Nervous System Tumors;   Extragonadal Germ Cell Tumor;   Testicular Germ Cell Tumor
Interventions: Biological: filgrastim;   Biological: pegfilgrastim;   Drug: carboplatin;   Drug: cisplatin;   Drug: dexamethasone;   Drug: etoposide;   Drug: ifosfamide;   Other: high-dose chemotherapy with autologous stem cell rescue;   Other: laboratory biomarker analysis;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation
34 Recruiting T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Conditions: Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell Tumor
Interventions: Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: Data Collection
35 Unknown  Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
Conditions: Brain and Central Nervous System Tumors;   Extragonadal Germ Cell Tumor;   Ovarian Cancer;   Testicular Germ Cell Tumor
Interventions: Biological: filgrastim;   Biological: lenograstim;   Biological: pegfilgrastim;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: ifosfamide;   Drug: paclitaxel
36 Recruiting Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Condition: Cancer
Interventions: Biological: anti-thymocyte globulin;   Biological: rituximab;   Drug: clofarabine;   Procedure: stem cell transplantation
37 Unknown  Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors
Conditions: Extragonadal Germ Cell Tumor;   Teratoma;   Testicular Germ Cell Tumor
Interventions: Biological: bleomycin sulfate;   Biological: pegfilgrastim;   Drug: cisplatin;   Drug: etoposide
38 Recruiting Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant
Conditions: Cancer Survivor;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Neuroblastoma;   Testicular Germ Cell Tumor
Interventions: Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: laboratory biomarker analysis
39 Recruiting Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Condition: Cancer
Interventions: Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review;   Other: questionnaire administration;   Procedure: assessment of therapy complications;   Procedure: evaluation of cancer risk factors
40 Unknown  Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
Conditions: Extragonadal Germ Cell Tumor;   Teratoma;   Testicular Germ Cell Tumor
Interventions: Biological: bleomycin sulfate;   Drug: cisplatin;   Drug: etoposide;   Drug: ifosfamide;   Drug: oxaliplatin;   Drug: paclitaxel

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-52) Show next page of results
Indicates status has not been verified in more than two years